Tempus ✓
@TempusAI · Chicago, IL · joined 09 Oct 2015
Tempus is a technology company leading the adoption of #AI to advance precision medicine.
15 106Followers
1 136Following
1 449Posts total
61.7KViews on collected posts
Últimas publicaciones
Buscando publicaciones nuevas…
#WorldCBCDx is right around the corner.
Join our CSO, Kate Sasser and Said Francis, Chief Business Officer and General Manager of Individualized Neoantigen Therapies at @moderna_tx , for a fireside chat discussing how combining #NGS and advanced therapeutic platforms is https://
1.2K views · 18 likes
· 2 reposts · 0 replies
Open on X →
We are excited to announce an extension of our data license agreement with @RecursionPharma through November 2029, building on our shared mission to advance precision medicine using AI foundation models.
As part of this expanded multi-year partnership, we have also entered into
8.1K views · 98 likes
· 12 reposts · 1 replies
Open on X →
Understanding the complex immune landscape of platinum-resistant #ovariancancer (PROC) is critical to advancing targeted therapies.
In a recent analysis featured in the Tempus Lens Library, researchers evaluated B7-H4 co-expression and PD-L1 prevalence in patients with PROC. By
1.8K views · 35 likes
· 3 reposts · 1 replies
Open on X →
0:20
@TempusAI @lefkofsky @CNBC Personalized care at scale only works if data quality, consent, and clinical accountability scale with it. The strategic advantage is not simply more models; it is a trusted longitudinal data layer that clinicians can use and patients can understand.
28 views · 0 likes
· 0 reposts · 0 replies
Open on X →
This #BloodCancerAwarenessMonth, we're proud to support @BloodCancerUtd's Dream Project in its mission to transform pediatric blood cancer care by empowering patients with their health data and fueling scientific breakthroughs.
Partnering on this project advances our shared htt
2K views · 34 likes
· 2 reposts · 2 replies
Open on X →
@TempusAI @lefkofsky @CNBC Tempus maps the tumour.
Moderna codes a unique vaccine against the tumour and bolts that onto the $32 billion Keytruda machine.
Two platforms, one patient, paired across every cancer the machine already touches. https://t.co/QoaibxmAgI
473 views · 4 likes
· 0 reposts · 0 replies
Open on X →
"Healthcare will likely be the biggest beneficiary of AI."
Our Founder & CEO @lefkofsky joined @CNBC to share how intelligent diagnostics and data are unlocking personalized care at scale.
Watch the interview: https://t.co/vZOuEtx0f0
15.7K views · 105 likes
· 12 reposts · 4 replies
Open on X →
@TempusAI @PersonalisInc The longitudinal monitoring angle is the part worth slowing down on. Tempus acquiring Personalis deepens the data asset, sure, but the harder question is whether that depth actually translates into licensing revenue that a health system CFO can point to o
66 views · 0 likes
· 0 reposts · 0 replies
Open on X →
@TempusAI @PersonalisInc @TempusAI @lefkofsky Are you happy ? https://t.co/5BGjT0mKPB
185 views · 3 likes
· 0 reposts · 0 replies
Open on X →
@TempusAI @PersonalisInc @lefkofsky @TempusAI $TEM
Down 70% in 1 year
While shareholders are committing suicide and dying, the company’s executives are selling their shares and living comfortably.
I hope the company and its executives experience every bit of the pain their sha
500 views · 6 likes
· 0 reposts · 3 replies
Open on X →
Today, we announced an agreement to acquire @PersonalisInc , building on our strategic partnership that began in 2023.
Bringing Personalis’ capabilities together with Tempus’ scale, data and commercial capabilities has the potential to expand access to longitudinal monitoring, h
31.4K views · 59 likes
· 6 reposts · 5 replies
Open on X →
Frente a cuentas del mismo tamaño
13 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. justo en la mediana de su rango de seguidores.
Visualizaciones medianas500esta cuenta924mediana de 10K–100K
Alcance, %3.31%esta cuenta3.62%mediana de 10K–100K
Interacción, %1.41%esta cuenta1.52%mediana de 10K–100K
| Métrica | Esta cuenta | Mediana de 10K–100K | Proporción |
|---|---|---|---|
| Visualizaciones medianas por publicación | 500 | 924 | 0.54× |
| Alcance (visualizaciones ÷ seguidores) | 3.31% | 3.62% | 0.91× |
| Tasa de interacción | 1.41% | 1.52% | 0.93× |
Otras cuentas de este rango → Comparar con otra cuenta → Cómo se construyen estas referencias →
Growth & engagement
How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.
Views per post
31.4K20 Jul
500
185
6621 Jul
15.7K14 Sep
473
9115 Sep
2K
2816 Sep
1.8K18 Sep
8.1K21 Sep
210
1.2K23 Sep
Last 13 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.
Engagement rate per post
0.25%20 Jul
1.80%
1.62%
0.00%21 Jul
0.81%14 Sep
0.85%
0.00%15 Sep
1.93%
0.00%16 Sep
2.21%18 Sep
1.41%21 Sep
1.90%
1.68%23 Sep
Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.
What the audience does
Likes75.4%365 in total
Reposts7.6%37 in total
Replies3.5%17 in total
Quotes3.5%17 in total
Bookmarks9.9%48 in total
Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.
The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.
Cuentas similares
Ali Watkins
@AliWatkins
30.2K followers
· 19K posts
Delta Center ✓
@deltacenter
30.2K followers
· 9.7K posts
🏹🇧🇷 Arqueiro JB 🇧🇷🏹🙏🏻
@ArqueiroJB
30.2K followers
· 17.5K posts
Bob Moore
@BobMooreNews
30.2K followers
· 27.4K posts
diplomata de barzinho
@diplomatadebarz
30.2K followers
· 21.7K posts
Int Society of Nephrology ✓
@ISNkidneycare
30.2K followers
· 24.9K posts
UE au Burundi
@UEauBurundi
30.2K followers
· 1.9K posts
EFE Verifica ✓
@EFEVerifica
30.2K followers
· 13K posts